«Not only could the test have a major impact on treatment of prostate cancer, but it could also be adapted to open up the possibility of precision medicine to
patients with other types of cancer as well.»
Better screening and treatment have meant that
patients with other types of cancer — particularly breast, prostate and colon cancer — are living long enough to die of something else.
Patients with other types of cancer have reported similar problems.
Of 10
patients with other types of cancer — including pancreatic, prostate, and uterine — who had mismatch repair mutations, in seven their tumors shrank or remained stable; the other three progressed.